Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42581589)
Watch
English
Risperidone for schizophrenia
scientific article published on May 1994
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
editorial
0 references
title
Risperidone for schizophrenia
(English)
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
main subject
schizophrenia
1 reference
based on heuristic
inferred from title
risperidone
1 reference
based on heuristic
inferred from title
author name string
Edwards JG
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
language of work or name
English
0 references
publication date
1 May 1994
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
published in
The BMJ
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
volume
308
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
issue
6940
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
page(s)
1311-1312
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
cites work
Survey on the pharmacodynamics of the new antipsychotic risperidone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Risperidone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Biochemical profile of risperidone, a new antipsychotic
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Risperidone: clinical safety and efficacy in schizophrenia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540264
retrieved
28 May 2018
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7517246
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7517246
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1136/BMJ.308.6940.1311
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
PMCID
2540264
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
PubMed ID
7517246
1 reference
stated in
Europe PubMed Central
PMCID
2540264
retrieved
3 November 2017
ResearchGate publication ID
15682353
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
